PHARMACOPEIA, INC.
Patent Owner
Stats
- 20 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 09, 2014 most recent publication
Details
- 20 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,092 Total Citation Count
- Jun 07, 1995 Earliest Filing
- 37 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8017616 Heterocyclic substituted pyridine compounds with CXCR3 antagonist activityDec 21, 09Sep 13, 11[A61K, C07D]
7951803 8-heteroarylpurine MNK2 inhibitors for treating metabolic disordersMar 09, 07May 31, 11[A61K, C07D, A61P]
7902199 Heterocyclic substituted piperazine compounds with CXCR3 antagonist activityJul 12, 07Mar 08, 11[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8501747 Functionally selective alpha2C adrenoreceptor agonistsExpiredFeb 11, 08Aug 06, 13[A61K, C07D]
8003624 Functionally selective ALPHA2C adrenoreceptor agonistsExpiredFeb 13, 07Aug 23, 11[A01N, C07D]
7691856 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligandsExpiredJan 09, 07Apr 06, 10[A61K, C07D]
7511049 Pyrazolopyrimidines as cyclin dependent kinase inhibitorsExpiredJul 17, 07Mar 31, 09[A61K, C07D, A61P]
2009/0005,568 Substituted 2-aminothiazoles for treating neurodegenerative diseasesAbandonedAug 18, 06Jan 01, 09[A61K, C07D, A61P]
2008/0045,489 3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDSAbandonedJul 05, 07Feb 21, 08[A61K, C07D, A61P]
2007/0054,925 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitorsAbandonedMar 31, 06Mar 08, 07[A61K, C07D]
6903131 3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonistsExpiredOct 11, 02Jun 07, 05[A61K, C07D]
6806056 Fluorescent capture assay for kinase activity employing an anti-phosphotyrosine antibody as both the capture agent and detecting agentExpiredApr 18, 02Oct 19, 04[G01N]
2004/0186,142 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligandsAbandonedOct 07, 03Sep 23, 04[A61K, C07D]
2003/0204,085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonistsAbandonedJul 30, 02Oct 30, 03[C07D, C07C]
2003/0139,435 N-heterocyclic inhibitors of TNF-alpha expressionAbandonedJun 26, 02Jul 24, 03[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
